These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33499156)

  • 1. Depleted Myocardial Coenzyme Q10 in Cavalier King Charles Spaniels with Congestive Heart Failure Due to Myxomatous Mitral Valve Disease.
    Christiansen LB; Reimann MJ; Schou-Pedersen AMV; Larsen S; Lykkesfeldt J; Olsen LH
    Antioxidants (Basel); 2021 Jan; 10(2):. PubMed ID: 33499156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of Repeated Oral Dosing with Coenzyme Q10 in Cavalier King Charles Spaniels with Myxomatous Mitral Valve Disease.
    Christiansen LB; Morsing MK; Reimann MJ; Martinussen T; Birlie Z; Schou-Pedersen AMV; Lykkesfeldt J; Olsen LH
    Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32899633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.
    Sudunagunta S; Green D; Christley R; Dukes-McEwan J
    J Vet Cardiol; 2019 Jun; 23():21-31. PubMed ID: 31174726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.
    Cremer SE; Singletary GE; Olsen LH; Wallace K; Häggström J; Ljungvall I; Höglund K; Reynolds CA; Pizzinat N; Oyama MA
    J Vet Intern Med; 2014; 28(5):1534-40. PubMed ID: 25146933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine 5-hydroxyindoleacetic acid in Cavalier King Charles spaniels with preclinical myxomatous mitral valve disease.
    Christiansen LB; Cremer SE; Helander A; Madsen T; Reimann MJ; Møller JE; Höglund K; Ljungvall I; Häggström J; Olsen LH
    Vet J; 2019 Aug; 250():36-43. PubMed ID: 31383418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
    Rasmussen CE; Falk T; Zois NE; Moesgaard SG; Häggström J; Pedersen HD; Ablad B; Nilsen HY; Olsen LH
    J Vet Intern Med; 2012; 26(1):76-84. PubMed ID: 22151356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating MiR-30b-5p is upregulated in Cavalier King Charles Spaniels affected by early myxomatous mitral valve disease.
    Bagardi M; Ghilardi S; Zamarian V; Ceciliani F; Brambilla PG; Lecchi C
    PLoS One; 2022; 17(7):e0266208. PubMed ID: 35816500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiographic Evaluation of the Mitral Valve in Cavalier King Charles Spaniels.
    Bagardi M; Bionda A; Locatelli C; Cortellari M; Frattini S; Negro A; Crepaldi P; Brambilla PG
    Animals (Basel); 2020 Aug; 10(9):. PubMed ID: 32825079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitral valve transcriptome analysis in thirty-four age-matched Cavalier King Charles Spaniels with or without congestive heart failure caused by myxomatous mitral valve disease.
    Reimann MJ; Cremer S; Christiansen L; Ibragimov E; Gao F; Cirera S; Fredholm M; Olsen LH; Karlskov-Mortensen P
    Mamm Genome; 2024 Mar; 35(1):77-89. PubMed ID: 37938355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective pilot study on the predictive significance of plasma miR-30b-5p through the study of echocardiographic modifications in Cavalier King Charles Spaniels affected by different stages of myxomatous mitral valve disease: The PRIME study.
    Ghilardi S; Lecchi C; Bagardi M; Romito G; Colombo FM; Polli M; Franco C; Brambilla PG
    PLoS One; 2022; 17(12):e0274724. PubMed ID: 36574372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Morphometry on Echocardiographic Measurements in Cavalier King Charles Spaniels: An Inverse Probability Weighting Analysis.
    Bagardi M; Ghilardi S; Locatelli C; Bionda A; Polli M; Bussadori CM; Colombo FM; Pazzagli L; Brambilla PG
    Vet Sci; 2021 Sep; 8(10):. PubMed ID: 34679035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and serum serotonin concentrations and surface-bound platelet serotonin expression in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
    Cremer SE; Kristensen AT; Reimann MJ; Eriksen NB; Petersen SF; Marschner CB; Tarnow I; Oyama MA; Olsen LH
    Am J Vet Res; 2015 Jun; 76(6):520-31. PubMed ID: 26000599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Echocardiographic Findings in an Aged Population of Cavalier King Charles Spaniels.
    Prieto Ramos J; Corda A; Swift S; Saderi L; De La Fuente Oliver G; Corcoran B; Summers KM; French AT
    Animals (Basel); 2021 Mar; 11(4):. PubMed ID: 33800666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Coenzyme Q
    Druzhaeva N; Nemec Svete A; Tavčar-Kalcher G; Babič J; Ihan A; Pohar K; Krapež U; Domanjko Petrič A
    Antioxidants (Basel); 2022 Jul; 11(8):. PubMed ID: 35892628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Variants at the Nebulette Locus Are Associated with Myxomatous Mitral Valve Disease Severity in Cavalier King Charles Spaniels.
    Mead SE; Beijerink NJ; O'Brien M; Wade CM
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of 2 loci associated with development of myxomatous mitral valve disease in Cavalier King Charles Spaniels.
    Madsen MB; Olsen LH; Häggström J; Höglund K; Ljungvall I; Falk T; Wess G; Stephenson H; Dukes-McEwan J; Chetboul V; Gouni V; Proschowsky HF; Cirera S; Karlskov-Mortensen P; Fredholm M
    J Hered; 2011; 102 Suppl 1():S62-7. PubMed ID: 21846748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating cytokine concentrations in dogs with different degrees of myxomatous mitral valve disease.
    Zois NE; Moesgaard SG; Kjelgaard-Hansen M; Rasmussen CE; Falk T; Fossing C; Häggström J; Pedersen HD; Olsen LH
    Vet J; 2012 Apr; 192(1):106-11. PubMed ID: 21696985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between syringomyelia and myxomatous mitral valve disease in Cavalier King Charles spaniels.
    Bach MBT; Stougaard CL; Thøfner MS; Reimann MJ; Westrup U; Koch J; Fredholm M; Martinussen T; Berendt M; Olsen LH
    J Vet Intern Med; 2024; 38(2):904-912. PubMed ID: 38391152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the serotonin transporter gene and circulating concentrations of neurotransmitters in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
    Reimann MJ; Fredholm M; Cremer SE; Christiansen LB; Meurs KM; Møller JE; Häggström J; Lykkesfeldt J; Olsen LH
    J Vet Intern Med; 2021 Nov; 35(6):2596-2606. PubMed ID: 34599615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopterin status in dogs with myxomatous mitral valve disease is associated with disease severity and cardiovascular risk factors.
    Reimann MJ; Häggström J; Mortensen A; Lykkesfeldt J; Møller JE; Falk T; Olsen LH
    J Vet Intern Med; 2014; 28(5):1520-6. PubMed ID: 25274442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.